Oncoceutics

81 articles about Oncoceutics

• Oncoceutics Begins ONC201 Endometrial Cancer Trial; Receives NIH Grant

  9/13/2017

• Oncoceutics Release: ONC201 Trial For Neuroendocrine Cancer Begins At Cleveland Clinic

  8/14/2017

• Oncoceutics Release: Mechanistic Study Uncovers New Utility Of ONC201 Mechanism In Lymphoma

  7/14/2017

• Oncoceutics Extends Patent Family To Include ONC201 In Leukemias

  7/11/2017

• Oncoceutics Release: Cell Cycle Article Describes Anti-Cancer Efficacy Of Imipridones

  6/14/2017

• Oncoceutics Release: Efficacy Results For ONC201 In Recurrent Glioblastoma Published

  5/31/2017

• Oncoceutics Release: Research Publications Provide Rationale For ONC201 Trials In Breast Cancer

  5/4/2017

• Oncoceutics Release: Fox Chase Cancer Center Enrolling Patients In ONC201 Multiple Myeloma Trial

  5/1/2017

• Oncoceutics Release: ONC201 Phase I Trial Results Reported In Clinical Cancer Research

  3/28/2017

• Oncoceutics Presentations On ONC201 And Other Imipridones At AACR 2017

  3/28/2017

• Oncoceutics Expands DRD2 Research Collaborations With NIH

  3/16/2017

• Oncoceutics Promotes Lee Schalop, MD, To Chief Operating Officer

  11/23/2016

• Oncoceutics Release: Imipridone Activity Described In Multiple Abstracts At 2016 American Society of Hematology Meeting

  11/16/2016

• Oncoceutics Receives Additional US Patent For ONC201 In Adenocarcinomas

  9/29/2016

• Oncoceutics Release: Oncotarget Article Describes Development Of Imipridone ONC201

  9/16/2016

• Oncoceutics Release: ONC201 Continues To Show Excellent Safety When Dosed Weekly

  9/8/2016

• Oncoceutics Awarded FDA Orphan Grant For ONC201 Multiple Myeloma Trial

  8/17/2016

• ASCO2016: Oncoceutics Release: ONC201 Clinical Trial Results Accepted For 2016 ASCO Poster Discussion

  6/1/2016

• Oncoceutics Release: ONC201 Clinical Trial Results Accepted For 2016 ASCO Poster Discussion

  5/19/2016

• Oncoceutics Release: Live Like Bella Childhood Cancer Foundation Approves Grant To CHOP Oncologist To Study ONC201

  5/2/2016